Paraphernalia
PPubMed17 Oct 2024Cited 12×

Identification of tauopathy-associated lipid signatures in Alzheimer’s disease mouse brain using label-free chemical imaging

Hao Meng, Alicia Elliott, Jessica Mansfield, Michelle Bailey, Mark Frogley, Gianfelice Cinque, Julian Moger, Nick Stone, Francesco Tamagnini, Francesca Palombo

Abstract

There is cumulative evidence that lipid metabolism plays a key role in the pathogenesis of various neurodegenerative disorders including Alzheimer’s disease (AD). Visualising lipid content in a non-destructive label-free manner can aid in elucidating the AD phenotypes towards a better understanding of the disease. In this study, we combined multiple optical molecular-specific methods, Fourier transform infrared (FTIR) spectroscopic imaging, synchrotron radiation-infrared (SR-IR) microscopy, Raman and stimulated Raman scattering (SRS) microscopy, and optical-photothermal infrared (O-PTIR) microscopy with multivariate data analysis, to investigate the biochemistry of brain hippocampus in situ using a mouse model of tauopathy (rTg4510). We observed a significant difference in the morphology and lipid content between transgenic (TG) and wild type (WT) samples. Immunohistochemical staining revealed some degree of microglia co-localisation with elevated lipids in the brain. These results provide new evidence of tauopathy-related dysfunction in a preclinical study at a subcellular level.

A figure from Identification of tauopathy-associated lipid signatures in Alzheimer’s disease mouse brain using label-free chemical imaging
fig. from the paper

§ The Valyu brief

Reading the full paper and taking notes. This takes a few seconds…

§ Ask this paper

Ask a question about this paper

Valyu reads the full text and answers from what the paper actually says.

Q.

Searching the other archives…

Identification of tauopathy-associated lipid signatures in Alzheimer’s disease mouse brain using label-free chemical imaging · Paraphernalia